All Stories

  1. AI-Based Retinal Image Analysis for the Detection of Choroidal Neovascular Age-Related Macular Degeneration (AMD) and Its Association with Brain Health
  2. Automatic retinal image analysis methods using colour fundus images for screening glaucomatous optic neuropathy
  3. A New Model Selection Metric for Biomarker Detection Algorithms and Tools
  4. Robust time selection for interim analysis in the Bayesian phase 2 exploratory clinical trial
  5. An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysis
  6. Lifestyle Changes Reduced Estimated White Matter Hyperintensities Based on Retinal Image Analysis
  7. Digital solution for detection of undiagnosed diabetes using machine learning-based retinal image analysis
  8. A Prism Vote method for individualized risk prediction of traits in genotype data of Multi-population
  9. Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma
  10. Spatiotemporal relationship between temperature and non-accidental mortality: Assessing effect modification by socioeconomic status
  11. Health Disparity Resulting from the Effect of Built Environment on Temperature-Related Mortality in a Subtropical Urban Setting
  12. Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
  13. Risk Assessment of CHD Using Retinal Images with Machine Learning Approaches for People with Cardiometabolic Disorders
  14. Quantifying the effect of government interventions and virus mutations on transmission advantage during COVID-19 pandemic
  15. A Prism Vote Framework for Individualized Risk Prediction of Traits in Genome-wide Sequencing Data of Multiple Populations
  16. Temporal Patterns in the Evolutionary Genetic Distance of SARS-CoV-2 during the COVID-19 Pandemic
  17. Differences in the case fatality risks associated with SARS-CoV-2 Delta and non-Delta variants in relation to vaccine coverage: An early ecological study in the United Kingdom
  18. Characterization of key amino acid substitutions and dynamics of the influenza virus H3N2 hemagglutinin
  19. Clustering of Socioeconomic Data in Hong Kong for Planning Better Community Health Protection
  20. Real-time quantification of the transmission advantage associated with a single mutation in pathogen genomes: a case study on the D614G substitution of SARS-CoV-2
  21. A Bayesian method for synthesizing multiple diagnostic outcomes of COVID-19 tests
  22. Estimation of stroke severity with National Institutes of Health Stroke Scale grading and retinal features
  23. Long-term effectiveness of elderly health care voucher scheme strategies: a system dynamics simulation analysis
  24. An early assessment of a case fatality risk associated with P.1 SARS-CoV-2 lineage in Brazil: an ecological study
  25. Machine-learning method for localization of cerebral white matter hyperintensities in healthy adults based on retinal images
  26. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2
  27. Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness
  28. Clinical study of diabetic peripheral neuropathy screening by retinal vascular geometric parameters
  29. Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example
  30. In silico prediction of influenza vaccine effectiveness by sequence analysis
  31. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis
  32. Response to: Comment on “Pain Perception of the First Eye versus the Second Eye during Phacoemulsification under Local Anesthesia for Patients Going through Cataract Surgery: A Systematic Review and Meta-Analysis”
  33. Ambient temperature and relative humidity as possible drivers of the hand, foot, and mouth disease epidemics in Zhejiang Province, China
  34. Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data
  35. Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: A systematic review
  36. Independent association between meteorological factors, PM2.5, and seasonal influenza activity in Hangzhou, Zhejiang province, China
  37. Transmissibility of coronavirus disease 2019 in Chinese cities with different dynamics of imported cases
  38. Temporal patterns in the evolutionary genetic distance of SARS-CoV-2 during the COVID-19 pandemic
  39. A machine learning approach for retinal images analysis as an objective screening method for children with autism spectrum disorder
  40. Predicting the dominant influenza A serotype by quantifying mutation activities
  41. Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis
  42. Quantifying the importance of the key sites on haemagglutinin in determining the selection advantage of influenza virus: Using A/H3N2 as an example
  43. Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial
  44. Monitoring disease transmissibility of 2019 novel coronavirus disease in Zhejiang, China
  45. Clinical risk factors associated with recurrence of ischemic stroke within two years
  46. Characterization of the evolutionary dynamics of influenza A H3N2 hemagglutinin
  47. <p>Modelling the Measles Outbreak at Hong Kong International Airport in 2019: A Data-Driven Analysis on the Effects of Timely Reporting and Public Awareness</p>
  48. Stroke Occurring on the Left or Right Side of the Brain Can Be Identified by the Analysis of Retinal Images: A Case Control Study
  49. Epidemiological changes in measles infections in southern China between 2009 and 2016: a retrospective database analysis
  50. The Discriminative Efficacy of Retinal Characteristics on Two Traditional Chinese Syndromes in Association with Ischemic Stroke
  51. Were infections in migrants associated with the resurgence of measles epidemic during 2013–2014 in southern China? A retrospective data analysis
  52. wtest: an integrated R package for genetic epistasis testing
  53. Global cytokine/chemokine profile identifies potential progression prediction indicators in hand-foot-and-mouth disease patients with Enterovirus A71 infections
  54. Radiation-Induced Hypoglossal Nerve Palsy after Definitive Radiotherapy for Nasopharyngeal Carcinoma: Clinical Predictors and Dose-Toxicity Relationship
  55. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose–toxicity relationship
  56. Pain Perception of the First Eye versus the Second Eye during Phacoemulsification under Local Anesthesia for Patients Going through Cataract Surgery: A Systematic Review and Meta-Analysis
  57. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
  58. Effects of Kinesio tape on lower limb muscle strength, hop test, and vertical jump performances: a meta-analysis
  59. Association between meteorological factors, spatiotemporal effects, and prevalence of influenza A subtype H7 in environmental samples in Zhejiang province, China
  60. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI
  61. Mathematical modelling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden
  62. Identification of meteorological factors associated with human infection with avian influenza A H7N9 virus in Zhejiang Province, China
  63. Retinal image analytics detects white matter hyperintensities in healthy adults
  64. Targeting Adults for Supplementary Immunization Activities of Measles Control in Central China: A Mathematical Modelling Study
  65. Monitoring the age-specificity of measles transmissions during 2009-2016 in Southern China
  66. Incorporating methylation genome information improves prediction accuracy for drug treatment responses
  67. Gene-methylation epistatic analyses via the W-test identifies enriched signals of neuronal genes in patients undergoing lipid-control treatment
  68. A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes
  69. Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
  70. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
  71. Benefits and limitations of implementing Chronic Care Model (CCM) in primary care programs: A systematic review
  72. European Stroke Organisation Conference: Abstracts
  73. Approximate Bayesian algorithm to estimate the basic reproduction number in an influenza pandemic using arrival times of imported cases
  74. An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: A retrospective analysis of patient exposure histories in Zhejiang province, China
  75. Hsc70 regulates the IRES activity and serves as an antiviral target of enterovirus A71 infection
  76. Development of an automatic retinal image analysis (ARIA) for screening cerebral small vessel disease in the community
  77. Estimation of clinical parameters of chronic kidney disease by exhaled breath full-scan mass spectrometry data and iterative PCA with intensity screening algorithm
  78. Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
  79. Short Sleep Duration Increases Metabolic Impact in Healthy Adults: A Population-Based Cohort Study
  80. Abstract LB-254: Thymidylate synthase gene polymorphisms is negatively associated with gastric cancer survival
  81. Stratified polygenic risk prediction model with application to CAGI bipolar disorder sequencing data
  82. Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adults
  83. A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).
  84. Age, gender, and socioeconomic gradients in metabolic syndrome: biomarker evidence from a large sample in Taiwan, 2005–2013
  85. Prediction Factors of Recurrent Stroke among Chinese Adults Using Retinal Vasculature Characteristics
  86. A Zoom-Focus algorithm (ZFA) to locate the optimal testing region for rare variant association tests
  87. A statistical method utilizing information of imported cases to estimate the transmissibility for an influenza pandemic
  88. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China
  89. Airway disease and environmental aeroallergens in eczematics approaching adulthood
  90. Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
  91. Epidemiological study of hypertensive retinopathy in the primary care setting: Retrospective cross-sectional review of retinal photographs
  92. Clinically important difference of Stroke-Specific Quality of Life Scale for aneurysmal subarachnoid hemorrhage
  93. A clustering approach to identify rare variants associated with hypertension
  94. Use of a least absolute shrinkage and selection operator (LASSO) model to selected ion flow tube mass spectrometry (SIFT-MS) analysis of exhaled breath to predict the efficacy of dialysis: a pilot study
  95. A fast and powerful W-test for pairwise epistasis testing
  96. A W‐test collapsing method for rare‐variant association testing in exome sequencing data
  97. Prospective Association between Diabetic Retinopathy and Cardiovascular Disease—A Systematic Review and Meta-analysis of Cohort Studies
  98. Electroacupuncture and splinting versus splinting alone to treat carpal tunnel syndrome: a randomized controlled trial
  99. Genetic evolution of Human Enterovirus A71 subgenotype C4 in Shenzhen, China, 1998–2013
  100. A fast and powerfulW-test for pairwise epistasis testing
  101. Concurrent epidemics of influenza A/H3N2 and A/H1N1pdm in Southern China: A serial cross-sectional study
  102. Retinal Information is Independently Associated with Cardiovascular Disease in Patients with Type 2 diabetes
  103. Interpreting the transmissibility of the avian influenza A(H7N9) infection from 2013 to 2015 in Zhejiang Province, China
  104. The diminishing socioeconomic disparity in obesity in a Chinese population with rapid economic development: analysis of serial cross-sectional health survey data 2002–2010
  105. Cognitive outcome in acute simvastatin treatment for aneurysmal subarachnoid hemorrhage: A propensity matched analysis
  106. Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage
  107. Detection of Nasopharyngeal Carcinoma by MR Imaging: Diagnostic Accuracy of MRI Compared with Endoscopy and Endoscopic Biopsy Based on Long-Term Follow-Up
  108. Mixed response and time-to-event endpoints for multistage single-arm phase II design
  109. Patient Flow Evaluation with System Dynamic Model in an Emergency Department: Data Analytics on Daily Hospital Records
  110. Risk-Adjusted Monitoring Method for Surgical Data: Methodology for Data Analytics (Work in Progress)
  111. Two Screening Methods for Genetic Association Study with Application to Psoriasis Microarray Data Sets
  112. High-Dose Simvastatin for Aneurysmal Subarachnoid Hemorrhage
  113. Identifying Meteorological Drivers for the Seasonal Variations of Influenza Infections in a Subtropical City — Hong Kong
  114. Four pairs of gene–gene interactions associated with increased risk for type 2 diabetes (CDKN2BAS–KCNJ11), obesity (SLC2A9–IGF2BP2, FTO–APOA5), and hypertension (MC4R–IGF2BP2) in Chinese women
  115. Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
  116. Interleukin-27 Is Differentially Associated with HIV Viral Load and CD4+ T Cell Counts in Therapy-Naïve HIV-Mono-Infected and HIV/HCV-Co-Infected Chinese
  117. Changes in pulmonary tuberculosis prevalence: evidence from the 2010 population survey in a populous province of China
  118. Risk factors and natural history of breast cancer in younger Chinese women
  119. Detection of Neovascularization Based on Fractal and Texture Analysis with Interaction Effects in Diabetic Retinopathy
  120. Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang
  121. Estimating the incidence reporting rates of new influenza pandemics at an early stage using travel data from the source country
  122. Cross Sectional Survey of Influenza Antibodies before and during the 2009 Pandemic in Shenzhen, China
  123. Segmentation and texture analysis with multimodel inference for the automatic detection of exudates in early diabetic retinopathy
  124. Modeling the impact of air, sea, and land travel restrictions supplemented by other interventions on the emergence of a new influenza pandemic virus
  125. A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiotherapy (CRT).
  126. Ultra-Early (within 24 Hours) Aneurysm Treatment After Subarachnoid Hemorrhage
  127. Health-Related Quality of Life After Aneurysmal Subarachnoid Hemorrhage: Profile and Clinical Factors
  128. Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
  129. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis
  130. Primary Nasopharyngeal Carcinoma: Diagnostic Accuracy of MR Imaging versus that of Endoscopy and Endoscopic Biopsy
  131. Association of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populations
  132. Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast
  133. Respone to Letter by Keller and Muroi
  134. Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural ne...
  135. Plasma Magnesium Concentrations and Clinical Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients
  136. Phase I portion of the phase I-II study of the X-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
  137. Intravenous Magnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage (IMASH)
  138. Human Papillomavirus DNA Detection in Menstrual Blood from Patients with Cervical Intraepithelial Neoplasia and Condyloma Acuminatum
  139. Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability
  140. Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms
  141. Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
  142. The application of wavelet-based neural network on DNA microarray data
  143. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma
  144. Factors related to sexual health in Chinese women with breast cancer in Hong Kong
  145. Quality of life (QOL) for breast cancer patients receiving aprepitant versus placebo for prevention of chemotherapy induced nausea and vomiting
  146. The impact of18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
  147. A randomized phase II study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
  148. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
  149. Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease
  150. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double‐blind, controlled trial using one side of the elbow or knee as a control
  151. Curcumin effects on blood lipid profile in a 6-month human study
  152. Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
  153. A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
  154. Nasopharyngeal Cancers: Which Method Should be Used to Measure these Irregularly Shaped Tumors on Cross-Sectional Imaging?
  155. A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy
  156. Digital PCR for the molecular detection of fetal chromosomal aneuploidy
  157. WS-02: Phase II Trials – endpoints, when to randomize
  158. Impact of SARS on development of childhood acute lymphoblastic leukaemia
  159. Detection of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC)
  160. Efficacy of neoadjuvant docetaxel and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma (NPC): A randomized phase II study
  161. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women
  162. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity
  163. Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma
  164. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma
  165. Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization
  166. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial
  167. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
  168. Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
  169. Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)
  170. Planned Equivalence or Noninferiority Trials Versus Unplanned Noninferiority Claims: Are They Equal?
  171. A Comparison of Wound Treatments in Nasopharyngeal Cancer Patients Receiving Radiation Therapy
  172. An Intensive Surveillance Program Detected a High Incidence of Hepatocellular Carcinoma Among Hepatitis B Virus Carriers With Abnormal Alpha-Fetoprotein Levels or Abdominal Ultrasonography Results
  173. A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
  174. P-832 Chinese herbal medicine (CHM) induces immuno-modulation in patients with advanced stage non-small lung cancer (NSCLC): A double-blind placebo-control randomized study
  175. A double-blind placebo-control randomized study of the efficacy of Chinese herbal medicine (CHM) in reduction of cytotoxic chemotherapy-induced toxicity
  176. A randomized phase II study of concurrent cisplatin-radiotherapy (RT) with or without neoadjuvant chemotherapy using docetaxel and cisplatin in advanced nasopharyngeal carcinoma (NPC)
  177. Impact of intensity-modulated radiotherapy (IMRT) on salivary gland function in early-stage nasopharyngeal carcinoma (NPC) patients: A prospective randomized study
  178. Quality of life as a predicting factor for survival in 235 patients with inoperable hepatocellar carcinoma (HCC)
  179. Subcutaneous amifostine for reduction of radiation xerostomia in nasopharynx cancer: A prospective randomised study
  180. Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
  181. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
  182. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience
  183. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group
  184. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group
  185. Knowledge, Perceptions, and Attitudes of Hong Kong Chinese Women on Screening Mammography and Early Breast Cancer Management
  186. Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer
  187. Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma
  188. Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes
  189. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience
  190. Quality of Life in Ovarian Cancer Patients: Comparison of Paclitaxel Plus Cisplatin, With Cyclophosphamide Plus Cisplatin in a Randomized Study
  191. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18
  192. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
  193. Prospective validation of serum CYFRA 21‐1, β‐2‐microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy
  194. Methodology for quality-of-life assessment: a critical appraisal
  195. Association of Human‐Leukocyte‐Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome
  196. Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA
  197. Determining the Relationship Between Toxicity and Quality of Life in an Ovarian Cancer Chemotherapy Clinical Trial
  198. Staging of Nasopharyngeal Carcinoma: Suggestions for Improving the Current UICC/AJCC Staging System11Presented in part at the 4th International UICC Symposium on Nasopharyngeal Carcinoma, Hong Kong, February 2003.
  199. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
  200. Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy
  201. Lamivudine for the prevention of hepatitis B virus reactivation in hbsag seropositive cancer patients undergoing cytotoxic chemotherapy
  202. Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein–Barr Virus DNA and Anti-Epstein–Barr Viral Capsid Antigen IgA Antibody
  203. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy
  204. Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group
  205. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
  206. A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma
  207. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma—a prospective study
  208. Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
  209. Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated type
  210. A comparison of the incidence, duration, and degree of the neurologic toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC)
  211. Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?
  212. Radiotherapy in soft-tissue sarcoma
  213. Radiotherapy in soft-tissue sarcoma
  214. Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma
  215. Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European O...
  216. Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma
  217. A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study
  218. A Phase I–II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
  219. Quantitative measurement of post‐irradiation neck fibrosis based on the young modulus
  220. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
  221. Adequate Lymph Node Staging Is Fundamental to Comparative Study on Resectable Non–Small-Cell Lung Cancer
  222. Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
  223. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system
  224. Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group
  225. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon‐alpha, doxorubicin and 5‐fluorouracil chemotherapy
  226. Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group
  227. Correlations between target scores and anchor ratings on a health transition questionnaire
  228. Determination of RhD Zygosity: Comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach
  229. Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
  230. Three-dimensional metacarpophalangeal joint kinematics using two markers on the phalanx
  231. Application of a New Multinomial Phase II Stopping Rule Using Response and Early Progression
  232. Application of Classification Tree and Neural Network Algorithms to the Identification of Serological Liver Marker Profiles for the Diagnosis of Hepatocellular Carcinoma
  233. Improved local control for early T-stage nasopharyngeal carcinoma – a tale of two hospitals
  234. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma
  235. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma
  236. Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast Cancer
  237. Dexamethasone for the Prophylaxis of Radiation-Induced Emesis: A National Cancer Institute of Canada Clinical Trials Group Phase III Study
  238. Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  239. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
  240. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose–tumor-control relationship above conventional tumoricidal dose
  241. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
  242. Second primary malignancies following the treatment of early stage ovarian cancer: Update of a study by the National Cancer Institute of Canada—Clinical Trials Group (NCIC—CTG)
  243. Gait assessment in unicompartmental knee arthroplasty patients: Principal component modelling of gait waveforms and clinical status
  244. Virulizin® - a review of its antineoplastic activity
  245. Randomized Phase II Study of High-Dose Paclitaxel With or Without Amifostine in Patients With Metastatic Breast Cancer
  246. A brain cancer clinical assessment tool (BC CAT) for monitoring disease status in high-grade gliomas
  247. A comparison of the neurological toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC)
  248. Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule
  249. The palliative effect of chemotherapy (CT) in metastatic breast cancer (MBC): objective tumour response is associated with symptom (Sx) improvement
  250. Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group
  251. MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
  252. Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
  253. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer
  254. Can the Q-TWiST method provide information on patients' preferences without collecting preference data from the patients? Quality-Adjusted Time Without Symptoms or Toxicity.
  255. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer.
  256. Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study
  257. Trauma Patients with Multiple Extremity Injuries
  258. Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma.
  259. Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.
  260. Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group
  261. Growth curve model analysis for quality of life data
  262. Growth curve model analysis for quality of life data
  263. Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
  264. Interpreting the significance of changes in health-related quality-of-life scores.
  265. Mammographic density in women on postmenopausal hormone replacement therapy
  266. Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30
  267. Gender and age influence baseline quality of life (QL) assessments in cancer patients
  268. Long term survivors from a European-Canadian trial of paclitaxel in platinum-pretreated ovarian cancer (OVCA)
  269. Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
  270. Effect of postchemotherapy nausea and vomiting on health-related quality of life
  271. Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National C...
  272. Configuration space analysis of the rheumatoid wrist
  273. Principal component models of knee kinematics and kinetics: Normal vs. pathological gait patterns
  274. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
  275. The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy
  276. Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival
  277. Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
  278. Validation of a 3D optoelectronic motion analysis system for the wrist joint
  279. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
  280. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
  281. Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity
  282. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
  283. Vascularity demonstrated by doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast
  284. Thermography: Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast
  285. Influence of age on the treatment of limited-stage small-cell lung cancer.
  286. Quality of Life Studies in Chemotherapy-Induced Emesis
  287. A proposal for a new approach to intergroup cancer trials
  288. Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
  289. Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.
  290. Changes in mean trabecular orientation in the medial condyle of the proximal tibia in osteoarthritis
  291. Trabecular microstructure in the medial condyle of the proximal tibia of patients with knee osteoarthritis
  292. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer
  293. Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting
  294. Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute...
  295. Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer
  296. Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma
  297. Assessing the Reliability of Two Toxicity Scales: Implications for Interpreting Toxicity Data
  298. Ondansetron Compared with Dexamethasone and Metoclopramide as Antiemetics in the Chemotherapy of Breast Cancer with Cyclophosphamide, Methotrexate, and Fluorouracil
  299. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
  300. Systemic Infusion Versus Bolus Chemotherapy with 5-Fluorouracil in Measurable Metastatic Colorectal Cancer
  301. Immunohistochemical Characteristics of Human Milk-fat Globule Antibodies in Predicting Chest Wall and Distant Metastasis After Mastectomy for Localized Cancer of the Breast
  302. Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer
  303. Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.
  304. Immunohistochemical reaction to human milk fat globule antibodies and breast cancer differentiation
  305. A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy
  306. Effect of daily etidronate on the osteolysis of multiple myeloma.
  307. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
  308. Thermography as a predictor of prognosis in cancer of the breast
  309. Trimetrexate: Predictors of Severe or Life-Threatening Toxic Effects
  310. Renal vascular histology and morphometry in systemic sclerosis. a case–control autopsy study
  311. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide